Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: Inhibition of inflammation by resolvin D1

American Journal of Neurodegenerative Diseases

Volumn 1, Issue 1, 2012, Pages 60-74

  Liu, Guanghao ^a   Fiala, Milan ^a   Mizwicki, Mathew T ^a   Sayre, James ^b   Magpantay, Larry ^a   Siani, Avi ^a   Mahanian, Michelle ^a   Chattopadhyay, Madhuri ^c   La Cava, Antonio ^a   Wiedau Pazos, Martina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyotrophic Lateral Sclerosis (ALS); Docosahexaenoic Acid (DHA); Inflammation; Interleukin 17A (IL 17A); Interleukin 6 (IL 6); Resolvin D1 (RvD1); Superoxide Dismutase 1 (SOD1); Tumor necrosis factor a

Indexed keywords

AUTACOID; CASPASE; CHEMOKINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; CYTOKINE; DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; RESOLVIN D1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; INFLAMMATION; MACROPHAGE; MALE; MIDDLE AGED; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; STIMULATION; UPREGULATION; VERY ELDERLY; YOUNG ADULT;

EID: 84980052315     PISSN: None     EISSN: 2165591X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kawamata T, Akiyama H, Yamada T and McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140: 691-707.
2. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR and Appel SH. Presence of dendritic cells, MCP-1, and activated microglia/ macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004; 55: 221-235.
3. Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, Chiappelli F, van Kooten C and Vinters HV. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 213-219.
4. Fiala M, Chattopadhay M, La Cava A, Tse E, Liu G, Lourenco E, Eskin A, Liu PT, Magpantay L, Tse S, Mahanian M, Weitzman R, Tong J, Nguyen C, Cho T, Koo P, Sayre J, Martinez-Maza O, Rosenthal MJ and Wiedau-Pazos M. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J Neuroinflammation 2010; 7: 76-90.
5. Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, Alexakis T, Tsoutsou A, Samakovli A, Michalopoulou M and Evdokimidis J. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? Acta Neurol Scand 2010; 122: 425-429.
6. Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destee A, Tonnel AB, Lassalle P and Just N. Elevated IL-6 and TNFalpha levels in patients with ALS: inflammation or hypoxia? Neurology 2005; 65: 1958-1960.
7. Sta M, Sylva-Steenland RM, Casula M, de Jong JM, Troost D, Aronica E and Baas F. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Neurobiol Dis 2011; 42: 211-220.
8. Henkel JS, Beers DR, Zhao W and Appel SH. Microglia in ALS: The Good, The Bad, and The Resting. J Neuroimmune Pharmacol 2009
9. Beers DR, Henkel JS, Zhao W, Wang J and Appel SH. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A 2008; 105: 15558-15563.
10. Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, Brown RH, Jr. and Carroll MC. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A 2008; 105: 17913-17918.
11. Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, Appel SH and Henkel JS. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun 2011; 25: 1025-1035.
12. Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, Forshew D, Madison C, Katz J, Miller RG and McGrath MS. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 2011; 230: 114-123.
13. Meissner F, Molawi K and Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A 2010; 107: 13046-13050.
14. Liu Y, Hao W, Dawson A, Liu S and Fassbender K. Expression of amyotrophic lateral sclerosislinked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. J Biol Chem 2009; 284: 3691-3699.
15. Keller AF, Gravel M and Kriz J. Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp Neurol 2011; 228: 69-79.
16. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S and Rothstein JD. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52: 771-778.
17. West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP, Hamdheydari L, Mai T, Mou S, Pye QN, Stewart C, West S, Williamson KS, Zemlan F and Hensley K. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem 2004; 91: 133-143.
18. Zhong Z, Ilieva H, Hallagan L, Bell R, Singh I, Paquette N, Thiyagarajan M, Deane R, Fernandez JA, Lane S, Zlokovic AB, Liu T, Griffin JH, Chow N, Castellino FJ, Stojanovic K, Cleveland DW and Zlokovic BV. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest 2009; 119: 3437-3449.
19. Takeuchi S, Fujiwara N, Ido A, Oono M, Takeuchi Y, Tateno M, Suzuki K, Takahashi R, Tooyama I, Taniguchi N, Julien JP and Urushitani M. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice. J Neuropathol Exp Neurol 2010; 69: 1044-1056.
20. Bailes JE and Mills JD. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J Neurotrauma 2010; 27: 1617-1624.
21. Marcheselli VL, Mukherjee PK, Arita M, Hong S, Antony R, Sheets K, Winkler JW, Petasis NA, Serhan CN and Bazan NG. Neuroprotectin D1/ protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 27-34.
22. Jicha GA and Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging 2010; 5: 45-61.
23. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83: 1505S-1519S.
24. Danthi SJ, Enyeart JA and Enyeart JJ. Modulation of native T-type calcium channels by omega-3 fatty acids. Biochem Biophys Res Commun 2005; 327: 485-493.
25. Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008; 19: 242-247.
26. Bannenberg G and Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta 2010; 1801: 1260-1273.
27. Serhan CN, Krishnamoorthy S, Recchiuti A and Chiang N. Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors. Curr Top Med Chem 2011
28. Neher JJ, Neniskyte U, Zhao JW, Bal-Price A, Tolkovsky AM and Brown GC. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol 2011; 186: 4973-4983.
29. Neniskyte U, Neher JJ and Brown GC. Neuronal death induced by nanomolar amyloid beta is mediated by primary phagocytosis of neurons by microglia. J Biol Chem 2011
30. Brooks BR, Miller RG, Swash M and Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
31. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B and Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999; 169: 13-21.
32. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, Whitelegge JP and Valentine JS. Initiation and elongation in fibrillation of ALSlinked superoxide dismutase. Proc Natl Acad Sci U S A 2008; 105: 18663-18668.
33. Zaghi J, Goldenson B, Inayathullah M, Lossinsky AS, Masoumi A, Avagyan H, Mahanian M, Bernas M, Weinand M, Rosenthal MJ, Espinosa-Jeffrey A, de Vellis J, Teplow DB and Fiala M. Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol 2009; 117: 111-124.
34. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006; 83: 447S-455S.
35. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G and Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002; 196: 1025-1037.
36. Korn T, Bettelli E, Oukka M and Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
37. Mir M, Asensio VJ, Tolosa L, Gou-Fabregas M, Soler RM, Llado J and Olmos G. Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants. Neuroscience 2009; 162: 959-971.
38. Gruol DL and Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997; 15: 307-339.
39. Marz P, Otten U and Rose-John S. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur J Neurosci 1999; 11: 2995-3004.
40. Ciric B, El-behi M, Cabrera R, Zhang GX and Rostami A. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 2009; 182: 5296-5305.
41. Miossec P, Korn T and Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.
42. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN and Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol 2011; 41: 366-379.
43. Merched AJ, Ko K, Gotlinger KH, Serhan CN and Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008; 22: 3595-3606.
44. Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K and Medley QG. Interregulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 2011; 131: 2428-2437.
45. Manel N, Unutmaz D and Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9: 641-649.
46. Akira S, Taga T and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1-78.